MiT family translocation-associated (TFE3 positive) renal cell carcinoma of childhood
暂无分享,去创建一个
[1] P. Argani,et al. Xp11.2 translocation renal cell carcinoma , 2018, European Urology Supplements.
[2] Dongmei Li,et al. Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis , 2016, PloS one.
[3] R. Mehra,et al. Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification. , 2016, Archives of pathology & laboratory medicine.
[4] R. Mehra,et al. MiT Family Translocation-Associated Renal Cell Carcinoma: A Contemporary Update With Emphasis on Morphologic, Immunophenotypic, and Molecular Mimics. , 2015, Archives of pathology & laboratory medicine.
[5] S. Sreehari,et al. Renal cell carcinoma with Xp11.2 translocation/TFE3 gene fusions -experience from a tertiary care hospital in Kerala, India , 2015 .
[6] Xiao-jun Zhou,et al. Xp11.2 Translocation Renal Cell Carcinomas Have a Poorer Prognosis Than Non-Xp11.2 Translocation Carcinomas in Children and Young Adults: A Meta-analysis , 2010, International journal of surgical pathology.